Occurrence of SV40 Neoplastic and Antigenic Information in Vaccine Strains of Adenovirus Type 3.
- 1 July 1966
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 122 (3) , 679-684
- https://doi.org/10.3181/00379727-122-31225
Abstract
Summary Adenovirus type 3 strain JF was propagated in its early passage history in rhesus monkey kidney cell cultures. Upon discovery of infectious SV40 in the adenovirus, further passages were carried out in African green monkey kidney cell cultures in the presence of SV40 antiserum. Following this procedure, two separate passage lines of the adenovirus were free of detectable infectious SV40, but vaccine seeds prepared from these lines (JF-1 and JF-2) induced in hamsters tumors which contained CF antigens identical to those found in tumors induced by SV40. These tumors, in turn, elicited serum antibodies that fixed complement with SV40 tumor and T antigens. In addition, both lots of adenovirus 3 strain JF induced the formation in human embryo kidney cells of SV40 antigen which was detected by the immuno-fluorescent technique. The induction of fluo-rescent-stainable SV40 T antigen in tissue culture was prevented by treatment of the virus with adenovirus type 3 neutralizing antiserum but not by treatment with SV40 neutralizing antiserum. This SV40 genetic material was presumably enclosed within adenovirus capsids. The findings are discussed as they related to the use of adenovirus vaccines in man. The authors are indebted to Mr. Horace C. Turner for the performance of the complement fixation tests and to Mrs. Lena Wetherell for technical assistance.This publication has 10 references indexed in Scilit:
- Occurrence of Adenovirus-SV40 Hybrids Among Monkey Kidney Cell Adapted Strains of Adenovirus.Experimental Biology and Medicine, 1966
- Potentiation of oncogenicity of adenovirus type 12 grown in African green monkey kidney cell cultures preinfected with SV40 virus. Persistence of both T antigens in the tumors and evidence for possible hybridization.Proceedings of the National Academy of Sciences, 1966
- Possible incorporation of SV40 genome within capsid proteins of adenovirus 4.Proceedings of the National Academy of Sciences, 1965
- THE INCORPORATION OF SV40 GENETIC MATERIAL INTO ADENOVIRUS 7 AS MEASURED BY INTRANUCLEAR SYNTHESIS OF SV40 TUMOR ANTIGENProceedings of the National Academy of Sciences, 1964
- EVIDENCE FOR A POSSIBLE GENETIC HYBRID BETWEEN ADENOVIRUS TYPE 7 AND SV40 VIRUSESProceedings of the National Academy of Sciences, 1964
- DETECTION OF SPECIFIC ANTIGEN IN SV40-TRANSFORMED CELLS BY IMMUNOFLUORESCENCEThe Journal of Experimental Medicine, 1964
- A SPECIFIC COMPLEMENT-FIXING ANTIGEN PRESENT IN SV40 TUMOR AND TRANSFORMED CELLSProceedings of the National Academy of Sciences, 1963
- Excretion of Vacuolating SV-40 Virus (Papova Virus Group) After Ingestion as a Contaminant of Oral Poliovaccine.Experimental Biology and Medicine, 1962
- Clinical and Serologic Responses in Volunteers Given Vacuolating Virus (SV40) by Respiratory RouteExperimental Biology and Medicine, 1961
- Serial Propagation of Adenoviruses (APG) in Monkey Kidney Tissue CulturesExperimental Biology and Medicine, 1956